Afroz, S., Parato, J., Shen, H., & Smith, S. S. (2016). Synaptic pruning in the female hippocampus is triggered at puberty by extrasynaptic GABAA receptors on dendritic spines. eLife, 5, e15106.
Bliss, T. V., & Collingridge, G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 361, 31-39.
Bliss, T. V., & Lomo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J.Physiol., 232, 331-356.
Briz, V., & Baudry, M. (2016). Calpains: Master Regulators of Synaptic Plasticity. Neuroscientist, 23, 221-231.
Cahill, M. E., Jones, K. A., Rafalovich, I., Xie, Z., Barros, C. S., Müller, U., & Penzes, P. (2012). Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. Mol.Psych., 17, 99–107.
Caillet-Saguy, C., Maisonneuve, P., Delhommel, F., Terrien, E., Babault, N., Lafon, M., . . . Wolff, N. (2015). Strategies to interfere with PDZ-mediated interactions in neurons: What we can learn from the rabies virus. Prog. Biophys. Mol. Biol., 119, 53-59.
Chi, C. N., Bach, A., Engstr€om, A., Wang, H., Strømgaard, K., Gianni, S., & Jemth, P. (2009). A Sequential Binding Mechanism in a PDZ Domain. Biochemistry, 48, 7089–7097.
Cisse, M., Duplan, E., Lorivel, T., Dunys, J., Bauer, C., & Checler, F. (2017). The transcription factor XBP1s restores hippocampal synaptic plasticity and memory by control of the Kalirin-7 pathway in Alzheimer model. Mol.Psych., 22, 1562-1575.
Deo, A. J., Cahill, M. E., Li, S., Goldszer, I., Lewis, D. A., Penzes, P., & Sweet, D. A. (2012). Increased expression of Kalirin-9 in the auditory cortex of schizophrenia subjects: Its role in dendritic pathology. Neurobiol Disease, 45, 796-803.
Flores, C. E., Li, X., Bennett, M. V. L., Nagy, J. I., & Pereda, A. E. (2008). Interaction between connexin35 and zonula occludens-1 and its potential role in the regulation of electrical synapses. Proc.Natl.Acad.Sci.USA, 105, 12545–12550.
Flores, C. E., Nannapaneni, S., Davidson, K. G. V., Yasumura, T., Bennett, M. V. L., Rash, J. E., & Pereda, A. E. (2012). Trafficking of gap junction channels at a vertebrate electrical synapse in vivo. Proc.Natl.Acad.Sci.USA, 109, E573–E582.
Garcia-Mata, R., & Burridge, K. (2006). Catching a GEF by its tail. Trends Cell Biol., 17, 36-43.
Grant, S. G. (2006). The synapse proteome and phosphoproteome: a new paradigm for synapse biology. Biochem. Soc. Trans, 34, 59-63.
Hill, J. J., Hashimoto, T., & Lewis, D. A. (2006). Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry, 11, 557-566.
Houslay, M. D. (2009). Disrupting specific PDZ domain-mediated interactions for therapeutic benefit. Brit.J.Pharm., 158, 483-485.
Kiraly, D. D., Lemtiri-Chlieh, F., Levine, E. S., Mains, R. E., & Eipper, B. A. (2011). Kalirin Binds the NR2B Subunit of the NMDA Receptor, Altering Its Synaptic Localization and Function. J. Neurosci, 31, 12554-12565.
Kiraly, D. D., Ma, X. M., Mazzone, C. M., Xin, X., & Mains, R. E. (2010). Behavioral and Morphological Responses to Cocaine Require Kalirin7. Biol. Psychiatry, 68, 249-255.
Kiraly, D. D., Nemirovsky, N. E., Larese, T. P., Tomek, S. E., Yahn, S. L., Olive, M. F., . . . Mains, R. E. (2013). Constitutive knockout of Kalirin-7 leads to increased rates of cocaine self-administration. Mol. Pharmacol, 84, 582-590.
Kushima, I., Nakamura, Y., Aleksic, B., Ikeda, M., Ito, Y., & Ozaki, N. (2012). Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. Schizo. Bull, 38, 552-560.
Larson, J., & Munkacsy, E. (2015). Theta-burst LTP. Brain Res., 1621, 38-50.
Larson, J., Wong, D., & Lynch, G. (1986). Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res., 368, 347-350.
Lee, S. H., Liu, L., Wang, Y. T., & Sheng, M. (2002). Clathrin Adaptor AP2 and NSF Interact with Overlapping Sites of GluR2 and Play Distinct Roles in AMPA Receptor Trafficking and Hippocampal LTD. Neuron, 36, 661–674.
Lemtiri-Chlieh, F., Zhao, L., Kiraly, D. D., Eipper, B. A., Mains, R. E., & Levine, E. S. (2011). Kalirin-7 is necessary for normal NMDA receptor-dependent synaptic plasticity. BMC Neurosci, 12:126, doi 10.1186/1471-2202-1112-1126. doi:10.1186/1471-2202-12-126
Lesch, K. P., Timmesfeld, N., Renner, T. J., Halperin, R., Stephan, D. A., & Jacob, C. (2008). Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J. Neural. Transm, 115, 1573-1585.
Lu, J., Luo, C., Bali, K. K., Xie, R. G., Mains, R. E., Eipper, B. A., & Kuner, R. (2015). A role for Kalirin-7 in nociceptive sensitization via activity-dependent modulation of spinal synapses. Nat. Commun, 6, 6820.
Luscher, C., Xia, H., Beattie, E. C., Carroll, R. C., von Zastrow, M., Malenka, R. C., & Nicoll, R. A. (1999). Role of AMPA Receptor Cycling in Synaptic Transmission and Plasticity. Neuron, 24, 649–658.
Luthi, A., Chittajallu, R., Duprat, F., Palmer, M. J., Benke, T. A., Kidd, F. L., . . . Collingridge, G. L. (1999). Hippocampal LTD Expression Involves a Pool of AMPARs Regulated by the NSF–GluR2 Interaction. Neuron, 24, 389-399.
Ma, X. M., Kiraly, D. D., Gaier, E. D., Wang, Kim, E. J., Levine, E. S., . . . Mains, R. E. (2008). Kalirin-7 is required for synaptic structure and function. J. Neurosci, 28, 12368-12382.
Ma, X. M., Miller, M. B., Vishwanatha, K. S., Gross, M. J., Wang, Y., Abbott, T., . . . Eipper, B. A. (2014). Nonenzymatic domains of Kalirin7 contribute to spine morphogenesis through interactions with phosphoinositides and Abl. Mol. Biol. Cell, 25, 1458-1471.
Ma, X. M., Wang, Y., Ferraro, F., Mains, R. E., & Eipper, B. A. (2008). Kalirin-7 Is an Essential Component of both Shaft and Spine Excitatory Synapses in Hippocampal Interneurons. J. Neurosci, 28, 711-724.
Mazzone, C. M., Larese, T. P., Kiraly, D. D., Eipper, B. A., & Mains, R. E. (2012). Analysis of Kalirin-7 knockout mice reveals different effects in female mice. Mol. Pharmacol, 82, 1241-1249.
Miller, M. B., Vishwanatha, K. S., Mains, R. E., & Eipper, B. A. (2015). An N-terminal Amphipathic Helix Binds Phosphoinositides and Enhances Kalirin Sec14 Domain-mediated Membrane Interactions. J. Biol. Chem, 290, 13541-13555.
Miller, M. B., Yan, Y., Eipper, B. A., & Mains, R. E. (2013). Neuronal Rho GEFs in Synaptic Physiology and Behavior. Neuroscientist, 19, 255-273.
Miller, M. B., Yan, Y., Machida, K., Kiraly, D. D., Levy, A. D., Wu, Y. I., . . . Mains, R. E. (2017). Brain region and isoform-specific phosphorylation alters Kalirin SH2 domain interaction sites and calpain sensitivity. ACS Chem. Neurosci., 8, 1554-1569.
Miller, M. B., Yan, Y., Wu, Y., Hao, B., Mains, R. E., & Eipper, B. A. (2017). Alternate promoter usage generates two subpopulations of the neuronal RhoGEF Kalirin-7. J. Neurochem., 140, 889-902.
Murray, P. S., Kirkwood, C. M., Gray, M. C., Ikonomovic, M. D., Penzes, P., & Sweet, R. A. (2012). beta-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol. Aging, 33, 2807-2812.
Nishimune, A., Isaac, J. T. R., Molnar, E., Noel, J., Nash, S. R., Tagaya, M., . . . Henley, J. M. (1998). NSF Binding to GluR2 Regulates Synaptic Transmission. Neuron, 21, 87-97.
Nugent, F. S., Hwong, A. R., Udaka, Y., & Kauer, J. A. (2008). High-Frequency Afferent Stimulation Induces Long-Term Potentiation of Field Potentials in the Ventral Tegmental Area. Neuropsychopharmacology, 33, 1704-1712.
Penzes, P., Johnson, R. C., Sattler, R., Zhang, X., Huganir, R. L., Kambampati, V., . . . Eipper, B. A. (2001). The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron, 29(1), 229-242.
Penzes, P., & Jones, K. A. (2008). Dendritic spine dynamics--a key role for kalirin-7. TINS, 31, 419-427.
Pichon, X., Wattiez, A. S., Becamel, C., Ehrlich, I., Bockaert, J., Eschalier, A., . . . Courteix, C. (2010). Disrupting 5-HT2A Receptor/PDZ Protein Interactions Reduces Hyperalgesia and Enhances SSRI Efficacy in Neuropathic Pain. Molecular Therapy, 18, 1462-1470.
Pim, D., Bergant, M., Boon, S. S., Ganti, K., Kranjec, C., Massimi, P., . . . Lawrence Banks, L. (2012). Human papillomaviruses and the specificity of PDZ domain targeting. FEBS J., 279, 3530–3537.
Rao, V. K., Zavala, G., Deb Roy, A., Mains, R. E., & Eipper, B. A. (2019). A pH-sensitive luminal His-cluster promotes interaction of PAM with V-ATPase along the secretory and endocytic pathways of peptidergic cells. J.Cell.Physiol., 234, 8683-8697.
Russell, T. A., Blizinsky, K. D., Cobia, D. J., Cahill, M. E., Xie, Z., Sweet, R. A., . . . Penzes, P. (2014). A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness. Nat.Commun. , 5:4858, doi: 10.1038/ncomms5858. doi:10.1038/ncomms5858
Sheng, M., & Hoogenraad, C. C. (2007). The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu. Rev. Biochem, 76, 823-847.
Sheng, M., & Kim, E. (2011). The Postsynaptic Organization of Synapses. Cold Spring Harb.Perspect.Biol., 3, a005678.
Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., & Cantley, L. C. (1997). Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science, 275, 73-77.
Vanderwolf, C. H. (1969). Hippocampal electrical activity and voluntary movement in the rat. Clin.Neurophysiol., 26, 407-418.
Walkup, W. G., & Kennedy, M. B. (2014). PDZ affinity chromatography: A general method for affinity purification of proteins based on PDZ domains and their ligands. Protein Expr. Purif., 98, 46-62.
Walkup, W. G., Mastro, T. L., Schenker, L. T., Vielmetter, J., Hu, R., Iancu, A., . . . Kennedy, M. B. (2016). A model for regulation by SynGAP-a1 of binding of synaptic proteins to PDZ-domain ’Slots’ in the postsynaptic density. eLife, 5, e16813.
Wang, L., Hauser, E. R., Shah, S. H., Pericak-Vance, M. A., Goldschmidt-Clermont, P. J., & Vance, J. M. (2007). Peakwide mapping on chromosome 3q13 identifies the Kalirin gene as a novel candidate gene for coronary artery disease. Am. J. Hum. Genet, 80, 650-663.
Wu, J. H., Fanaroff, A. C., Sharma, K. C., Zhang, L., Smith, L. S., Brian, L., . . . Freedman, N. J. (2012). Kalirin Promotes Neointimal Hyperplasia by Activating Rac in Smooth Muscle Cells. Arterioscler Thromb Vasc Biol, 33, 702-708.
Yan, Y., Eipper, B. A., & Mains, R. E. (2015). Kalirin-9 and Kalirin-12 play essential roles in dendritic outgrowth and branching. Cerebral Cortex, 25, 3487-3501.
Youn, H. S., Jeoung, M. K., Koo, Y. B., Ji, H., Markesbery, W. R., Ji, I., & Ji, T. H. (2007). Kalirin is under-expressed in Alzheimer's Disease hippocampus. J. Alzheimers Disease, 11, 385-397.
Youn, H. S., Ji, I., Ji, H., Markesbery, W. R., & Ji, T. H. (2007). Under-expression of Kalirin-7 Increases iNOS activity in cultured cells and correlates to elevated iNOS activity in Alzheimer's disease hippocampus. J. Alzheimers Disease, 12, 271-281.
Zhou, Z., Liu, A., Xia, S., Leung, C., Qi, J., Meng, Y., . . . Jia, Z. (2018). The C-terminal tails of endogenous GluA1 and GluA2 differentially contribute to hippocampal synaptic plasticity and learning. Nat.Neurosci., 21, 50-62.